WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

A SCRUTINY ON ROLE OF REMDESIVIR IN COVID-19 PANDEMIC

Arya Lekshmii U. S.*, Sowparnika Treasa Sabu and Shaiju S. Dharan

ABSTRACT

Background: The year 2020 begins with pandemic Covid-19 which is the infectious disease caused by SARS COV-2. The disease mainly affects the respiratory tract. The first case of respiratory tract illness was reported from Wuhan city in China. Researchers across the globe are carrying out various researches to develop a effective medicine for prevention and treatment of disease. Till now there is no standard treatment regiment available. A vaccine SPUTNIK-V was developed by the Russian scientists which is expected to provide immunity against SARS COV-2. Several antiviral as well as anti inflammatory agents were used as treatment regimen. Emergency use authorization of FDA approved the use of Remdisivir for the treatment of Covid-19 on 01 May 2020. The drug was authorized for emergency use in various countries like India, US, Singapore, Japan, Australia. Method: The review paper was prepared by referring research and review article from various sites like Pubchem, Pubmed, Google Scholar, European Medical Agency; Science Direct. Etc. Observation: Remdesivir is a drug with broad antiviral activity. It is Adenosine Triphsosphate Analogue which was developed for potential treatment of Ebola virus. Remdisivir is also active against Nipah respiratory Syncytialvirus. MERS-Cov. In various studies the drug has shown clinical improvement in patient as well as optimal safety profile was observed. Several studies are still continuing to picture out the efficiency and safety of Remdisivir in Covid-19 patients.

Keywords: SARS COV-2, Sputnik-V, Remdesivir, Adenosine Triphsosphate Analogue, Antiviral.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More